Lifting the differentiation embargo (original) (raw)

Latif, Anne-Louise and Holyoake, Tessa(2016) Lifting the differentiation embargo.Cell, 167(1), pp. 45-46. (doi: 10.1016/j.cell.2016.08.051) (PMID:27662083)

Abstract

Effective differentiation therapy for acute myeloid leukemia (AML) has been restricted to a small subset of patients with one defined genetic abnormality. Using an unbiased small molecule screen, Sykes et al. now identify a mechanism of de-repression of differentiation in several models of AML driven by distinct genetic drivers.

Item Type: Articles
Status: Published
Refereed: Yes
Glasgow Author(s) Enlighten ID: Holyoake, Professor Tessa and Latif, Dr Anne-Louise
Authors: Latif, A.-L., and Holyoake, T.
College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name: Cell
Publisher: Elsevier (Cell Press)
ISSN: 0092-8674
ISSN (Online): 1097-4172
Published Online: 22 September 2016
Copyright Holders: Copyright © 2016 Elsevier (Cell Press)
First Published: First published in Cell 167(1):45-46
Publisher Policy: Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record